세계의 초음파 시장 : 기술별, 디스플레이별, 휴대성별, 용도별, 구성요소별, 최종사용자별, 지역별 - 예측(-2030년)

The global ultrasound market is projected to reach USD 13.87 billion by 2030 from USD 9.32 billion in 2024, growing at a CAGR of 6.8% during the forecast period. The growth of the ultrasound market is driven by various key factors, including increasing prevalence rates of chronic diseases, such as cardiovascular conditions, cancer, and musculoskeletal disorders. These require sophisticated diagnostic equipment. Increasing demand for early diagnosis and non-invasive options also fuels adoption of the ultrasound technology. Advances in ultrasound itself, including AI integration, 3D/4D imaging, and portable equipment, make it more accessible and versatile in the clinical practice.

"Diagnostic Ultrasound to register largest market share in 2023"

Diagnostic ultrasound accounts for the largest share of the ultrasound market because it is capable of providing real-time, non-invasive imaging for a wide range of medical conditions. Its broad usage in obstetrics, cardiology, musculoskeletal imaging, and emergency care is contributing to its dominance. With this technology, it boasts such high accuracy, very low cost, and ionizing radiation-free; clinicians often turn to this for routine diagnostics. Improved ultrasound technology-3D/4D imaging, for instance, and AI-based tools have improved it so much that the use has remained on the growth track.

"Hospitals segment held the largest share of ultrasound equipment market in 2023, by End-user."

Hospitals have the largest market share in this ultrasound industry due to its high volume of patients and diversified departments, along with the requirements of advanced imaging diagnostics within a wide spectrum of specializations. Obsterics, cardiology, emergency care, and musculoskeletal imaging are key applications within the hospital setup that have integrated ultrasound technology. The increased cases of chronic diseases and hospital emphasis on earlier diagnosis and treatment create high demand for ultrasound systems. More importantly, the advanced functionalities of ultrasound, such as real-time imaging, non-invasiveness, and increased accuracy, make it of more importance to hospitals, thereby becoming their main consumers of ultrasound technology.

"Asia Pacific to register highest growth rate in the market during the forecast period."

The Asia-Pacific region is reporting the highest growth rate in the ultrasound market, with factors such as an increasingly prevalent chronic disease population, an aged population, and a widening healthcare infrastructure base. Growth in demand for early and accurate diagnoses coupled with the affordability of ultrasound and its non-invasive nature has further increased adoption across the region. Additionally, growing government efforts to expand the healthcare market, increasing investments in health, diagnostic center expansions, and increase in hospital numbers are leading the rapid growth of this market in the Asia-Pacific region. Technology advancement and the greater availability of portable ultrasound equipment facilitate wider accessibility and adoption in Asia-Pacific.

A number of drivers were responsible for the upswing, including:

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 40%, Tier 30%, and Tier 3 30%
• By Designation: C-level-- 55%, Director-level-27%, and Others-18%
• By Region: North America-35%, Europe-32%, Asia Pacific-25%, Latin America-6% , Middle East & Africa-2%

Prominent players in this market are Philips Healthcare (Netherlands), GE Healthcare (US), Canon Medical Systems Corporation (Japan), Siemens Healthineers (Germany), FUJIFILM Corporation (Japan), Hologic Inc.(US), Samsung Electronics Co., Ltd (South Korea), Esaote SPA (Italy), Chison Medical Technologies Co., Ltd (China), MobiSante Inc (US), Clarius (Canada), MedGyn Products, Inc (US), Promed Technology (China), Neusoft Corporation (China) among others.

Research Coverage

The ultrasound equipment market has been segmented based on technology, display, component, portability, application, end-user, and region. Key factors for the growth of the market include driving forces, restraints, opportunities, and challenges among the stakeholders. The study also looks into the competition of the leading players within the market. The further division of the market can be seen in micro-markets to gain insight into the growth trends, prospects, and contributions to the overall market. It highlights future revenue growth prospects for various market segments across five major regions.

Key Benefits of Buying the Report:

The report would be useful for new market entrants in the ultrasound market as it gives detailed information about the market. This helps get a good understanding of any investment opportunities. The report provides in-depth insight into key and smaller players which helps in doing strong risk assessment for investment decisions. This report segments the market precisely both by end-users and by regions for the purpose of attaining focused insights in the specific market segments. Additionally, it draws out the major trends, challenges, growth drivers, and opportunities to support the strategic decision-making process through adequate analysis.

The report provides the insights on the following pointers:

Analysis of the key drivers, restraints, opportunities, and challenges influencing the rise of the ultrasound market. The rise of point-of-care diagnostics and expanding healthcare infrastructure further boosts market growth. Additionally, favorable reimbursement policies and the need for early detection support ultrasound adoption.

Product Development/Innovation: The report includes emerging technologies in the domain, ongoing R&D activities, and recent product and service launches in the market for ultrasound market.

Market Development: It has elaborated about the new product development and unexplored markets, latest developments, and investment in the ultrasound market.

Market Diversification: Detailed insight into new product launches, unexplored markets, recent developments, and investments made in the ultrasound market.

Competitive Assessment: Detailed assessment of market share, service offerings leading strategies of key players such as Philips Healthcare (Netherlands), GE Healthcare (US), Canon Medical Systems Corporation (Japan), Siemens Healthineers (Germany), FUJIFILM Corporation (Japan), among others.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION
  • 1.3.2 INCLUSIONS & EXCLUSIONS
• 1.4 YEARS CONSIDERED
• 1.5 CURRENCY CONSIDERED
• 1.6 MARKET STAKEHOLDERS
• 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY RESEARCH
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY RESEARCH
    • 2.1.2.1 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Approach 1: Company revenue estimation approach
    • 2.2.1.2 Approach 2: Customer-based market estimation
    • 2.2.1.3 Approach 3: Top-down approach
    • 2.2.1.4 Approach 4: Primary interviews
• 2.3 DATA TRIANGULATION & MARKET BREAKDOWN
• 2.4 MARKET SHARE ASSESSMENT
• 2.5 STUDY ASSUMPTIONS
• 2.6 GROWTH RATE ASSUMPTIONS/MARKET FORECASTING METHODOLOGY
• 2.7 LIMITATIONS
• 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ULTRASOUND MARKET OVERVIEW
• 4.2 ULTRASOUND MARKET, BY REGION, 2022-2030
• 4.3 EUROPE: ULTRASOUND MARKET, BY REGION AND END USER, 2023
• 4.4 GEOGRAPHIC SNAPSHOT OF ULTRASOUND MARKET

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing prevalence of chronic diseases
    • 5.2.1.2 Rising patient preference for minimally invasive surgeries
    • 5.2.1.3 Rising technological advancements in ultrasound devices
    • 5.2.1.4 Growing public and private investments, funding, and grants
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Unfavorable reimbursements
    • 5.2.2.2 High operating costs
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growing applications of therapeutic ultrasound
    • 5.2.3.2 Growth in emerging markets
    • 5.2.3.3 Development of POC ultrasound devices
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Growing end-user preference for refurbished equipment
    • 5.2.4.2 Shortage of skilled sonographers
• 5.3 INDUSTRY TRENDS
  • 5.3.1 ENDOSCOPIC ULTRASOUND
  • 5.3.2 WIRELESS AND PORTABLE SYSTEMS
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 SUPPLY CHAIN ANALYSIS
  • 5.5.1 PROMINENT COMPANIES
  • 5.5.2 SMALL AND MEDIUM-SIZED ENTERPRISES
  • 5.5.3 END USERS
• 5.6 PORTER'S FIVE FORCES ANALYSIS
  • 5.6.1 THREAT OF NEW ENTRANTS
  • 5.6.2 BARGAINING POWER OF SUPPLIERS
  • 5.6.3 BARGAINING POWER OF BUYERS
  • 5.6.4 THREAT OF SUBSTITUTES
  • 5.6.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.7 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.7.2 BUYING CRITERIA
• 5.8 PATENT ANALYSIS
• 5.9 TRADE DATA ANALYSIS
  • 5.9.1 IMPORT DATA
  • 5.9.2 EXPORT DATA
• 5.10 KEY CONFERENCES & EVENTS, 2024-2025
• 5.11 UNMET NEEDS AND KEY PAIN POINTS
• 5.12 ECOSYSTEM ANALYSIS
• 5.13 IMPACT OF GEN AI ON ULTRASOUND MARKET
• 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.15 TECHNOLOGY ANALYSIS
  • 5.15.1 KEY TECHNOLOGIES
    • 5.15.1.1 Contrast-enhanced ultrasound (CEUS)
    • 5.15.1.2 Portable and handheld ultrasound devices
  • 5.15.2 COMPLEMENTARY TECHNOLOGIES
    • 5.15.2.1 Elastography
    • 5.15.2.2 Fluoroscopy
  • 5.15.3 ADJACENT TECHNOLOGIES
    • 5.15.3.1 PET/CT
• 5.16 CASE STUDY ANALYSIS
  • 5.16.1 LARGE-DIAMETER LUMEN-APPOSING METAL STENTS FOR WALLED-OFF NECROSIS
  • 5.16.2 PRENATAL DIAGNOSIS OF HYPOPHOSPHATASIA CONGENITAL USING ULTRASONOGRAPHY
  • 5.16.3 POSTOPERATIVE PERIRECTAL ABSCESS DRAINAGE
• 5.17 REGULATORY ANALYSIS
  • 5.17.1 NORTH AMERICA
    • 5.17.1.1 US
    • 5.17.1.2 Canada
  • 5.17.2 EUROPE
  • 5.17.3 ASIA PACIFIC
    • 5.17.3.1 Japan
    • 5.17.3.2 China
    • 5.17.3.3 India
  • 5.17.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.18 INVESTMENT & FUNDING SCENARIO
• 5.19 PRICING ANALYSIS
  • 5.19.1 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.19.2 AVERAGE SELLING PRICE FOR TOP 3 APPLICATIONS, BY KEY PLAYER
• 5.20 REIMBURSEMENT SCENARIO

6 ULTRASOUND MARKET, BY TECHNOLOGY

• 6.1 INTRODUCTION
• 6.2 DIAGNOSTIC ULTRASOUND
  • 6.2.1 2D ULTRASOUND
    • 6.2.1.1 Growing demand for minimally invasive surgeries to increase use of 2D ultrasound
  • 6.2.2 3D & 4D ULTRASOUND
    • 6.2.2.1 Improved diagnosis with 3D ultrasound technology to boost market growth
  • 6.2.3 DOPPLER ULTRASOUND
    • 6.2.3.1 Growing applications in cardiology and vascular to drive market growth
  • 6.2.4 CONTRAST-ENHANCED ULTRASOUND
    • 6.2.4.1 Enhanced diagnostic imaging with advanced ultrasound systems to boost demand
• 6.3 THERAPEUTIC ULTRASOUND
  • 6.3.1 HIGH-INTENSITY-FOCUSED ULTRASOUND
    • 6.3.1.1 Advancing cancer treatment with HIFU to fuel growth
  • 6.3.2 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY
    • 6.3.2.1 Enhancing urolithiasis treatment with advanced ESWL techniques and technologies to propel market

7 ULTRASOUND MARKET, BY DISPLAY

• 7.1 INTRODUCTION
• 7.2 COLOR ULTRASOUND
  • 7.2.1 GROWING DEMAND FOR COLOR ULTRASOUND TO SUPPORT MARKET GROWTH
• 7.3 BLACK & WHITE ULTRASOUND
  • 7.3.1 ENHANCED DIAGNOSTIC PRECISION WITH B/W ULTRASOUND TO DRIVE DEMAND

8 ULTRASOUND MARKET, BY PORTABILITY

• 8.1 INTRODUCTION
• 8.2 TROLLEY/CART-BASED ULTRASOUND SYSTEMS
  • 8.2.1 IMPROVED PATIENT EXPERIENCE WITH TROLLEY-BASED ULTRASOUND SYSTEMS TO DRIVE MARKET GROWTH
• 8.3 COMPACT/HANDHELD ULTRASOUND SYSTEMS
  • 8.3.1 GROWING NUMBER OF TRAUMA/EMERGENCY CASES TO FUEL MARKET GROWTH
• 8.4 POC ULTRASOUND DEVICES
  • 8.4.1 IMPROVED OPERATIONAL AND CLINICAL EFFICACY TO BOOST DEMAND FOR POC ULTRASOUND DEVICES

9 ULTRASOUND MARKET, BY APPLICATION

• 9.1 INTRODUCTION
• 9.2 RADIOLOGY/GENERAL IMAGING
  • 9.2.1 GROWING NUMBER OF CHRONIC DISEASES LEADING TO INCREASED USE OF THIS APPLICATION
• 9.3 CARDIOLOGY
  • 9.3.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASE ACROSS MAJOR HEALTHCARE MARKETS TO DRIVE GROWTH
• 9.4 OB/GYN
  • 9.4.1 WIDE ADOPTION OF AI IN ULTRASOUND IN FIELD OF OB/GYN TO BOOST MARKET
• 9.5 UROLOGY
  • 9.5.1 WIDE USE OF ULTRASOUND IN DIAGNOSIS AND TREATMENT OF VARIOUS UROLOGICAL DISORDERS TO DRIVE MARKET
• 9.6 VASCULAR
  • 9.6.1 VASCULAR APPLICATIONS SEGMENT TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
• 9.7 ORTHOPEDIC & MUSCULOSKELETAL
  • 9.7.1 RISING PREVALENCE OF OSTEOARTHRITIS TO DRIVE MARKET GROWTH
• 9.8 PAIN MANAGEMENT
  • 9.8.1 GROWING ADOPTION OF PORTABLE ULTRASOUND FOR PAIN MANAGEMENT TO SUPPORT GROWTH
• 9.9 PEDIATRIC
  • 9.9.1 GROWING USE OF PEDIATRIC ULTRASOUND TO COMBAT NEONATAL MORTALITY TO SPUR GROWTH
• 9.10 OTHER APPLICATIONS

10 ULTRASOUND MARKET, BY COMPONENT

• 10.1 INTRODUCTION
• 10.2 TRANSDUCERS/PROBES
  • 10.2.1 CURVILINEAR/CONVEX ARRAY PROBES
    • 10.2.1.1 Enhanced diagnosis with curvilinear and convex array ultrasound probes to boost market
  • 10.2.2 LINEAR ARRAY PROBES
    • 10.2.2.1 High-resolution power with linear array ultrasound systems to drive demand
  • 10.2.3 PHASED ARRAY PROBES
    • 10.2.3.1 Advanced imaging capabilities to drive market growth
  • 10.2.4 OTHER PROBES
• 10.3 WORKSTATIONS
  • 10.3.1 INCREASE IN DIAGNOSTIC PROCEDURES TO PROPEL DEMAND FOR WORKSTATIONS
• 10.4 OTHER COMPONENTS

11 ULTRASOUND MARKET, BY END USER

• 11.1 INTRODUCTION
• 11.2 HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS
  • 11.2.1 INCREASING PREVALENCE OF CANCER TO BOOST MARKET GROWTH
• 11.3 MATERNITY CENTERS
  • 11.3.1 INCREASED ADOPTION OF ADVANCED ULTRASOUND SYSTEMS FOR OB/GYN APPLICATIONS TO DRIVE MARKET GROWTH
• 11.4 AMBULATORY CENTERS
  • 11.4.1 INCREASING NUMBER OF SURGERIES TO PROPEL MARKET GROWTH
• 11.5 RESEARCH & ACADEMIC INSTITUTES
  • 11.5.1 GROWING NUMBER OF RESEARCH GRANTS TO BOOST MARKET GROWTH
• 11.6 OTHER END USERS

12 ULTRASOUND MARKET, BY REGION

• 12.1 INTRODUCTION
• 12.2 EUROPE
  • 12.2.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 12.2.2 GERMANY
    • 12.2.2.1 Growing healthcare expenditures and grants to drive market
  • 12.2.3 FRANCE
    • 12.2.3.1 Increasing population and rising number of centers to drive market
  • 12.2.4 UK
    • 12.2.4.1 Increasing prevalence of chronic diseases to contribute to market growth
  • 12.2.5 ITALY
    • 12.2.5.1 Increased availability of reimbursement coverage for diagnostic procedures to drive market
  • 12.2.6 SPAIN
    • 12.2.6.1 Growing focus on cancer research to support market growth
  • 12.2.7 REST OF EUROPE
• 12.3 NORTH AMERICA
  • 12.3.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 12.3.2 US
    • 12.3.2.1 Rise in cancer prevalence to drive market
  • 12.3.3 CANADA
    • 12.3.3.1 New product launches & conferences to drive market
• 12.4 ASIA PACIFIC
  • 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 12.4.2 CHINA
    • 12.4.2.1 Increasing acquisitions and partnerships to drive market
  • 12.4.3 JAPAN
    • 12.4.3.1 Established healthcare infrastructure and research facilities to drive market
  • 12.4.4 INDIA
    • 12.4.4.1 Government initiatives to drive market
  • 12.4.5 AUSTRALIA
    • 12.4.5.1 Growing healthcare spending and increasing investments in research to drive market
  • 12.4.6 SOUTH KOREA
    • 12.4.6.1 Well-developed healthcare system and conferences to drive market
  • 12.4.7 REST OF ASIA PACIFIC
• 12.5 LATIN AMERICA
  • 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 12.5.2 BRAZIL
    • 12.5.2.1 Greater purchasing power and favorable demographic conditions to drive market
  • 12.5.3 MEXICO
    • 12.5.3.1 Increased medical tourism and better government healthcare initiatives to drive market
  • 12.5.4 REST OF LATIN AMERICA
• 12.6 MIDDLE EAST & AFRICA
  • 12.6.1 GROWING QUALITY HEALTHCARE SYSTEMS TO DRIVE MARKET
  • 12.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 12.6.3 GCC COUNTRIES
    • 12.6.3.1 Developments in investment approach to drive market
  • 12.6.4 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

• 13.1 INTRODUCTION
• 13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ULTRASOUND MARKET
• 13.3 REVENUE ANALYSIS, 2019-2023
• 13.4 MARKET SHARE ANALYSIS, 2023
  • 13.4.1 RANKING OF KEY MARKET PLAYERS
• 13.5 COMPANY EVALUATION MATRIX: DIAGNOSTIC ULTRASOUND MARKET (KEY PLAYERS), 2023
  • 13.5.1 STARS
  • 13.5.2 EMERGING LEADERS
  • 13.5.3 PERVASIVE PLAYERS
  • 13.5.4 PARTICIPANTS
  • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 13.5.5.1 Company footprint
    • 13.5.5.2 Region footprint
    • 13.5.5.3 Technology footprint
    • 13.5.5.4 Display footprint
    • 13.5.5.5 Portability footprint
    • 13.5.5.6 Component footprint
    • 13.5.5.7 Application footprint
    • 13.5.5.8 End-user footprint
• 13.6 COMPANY EVALUATION MATRIX: THERAPEUTIC ULTRASOUND MARKET (STARTUPS/SMES), 2023
  • 13.6.1 PROGRESSIVE COMPANIES
  • 13.6.2 RESPONSIVE COMPANIES
  • 13.6.3 DYNAMIC COMPANIES
  • 13.6.4 STARTING BLOCKS
  • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 13.7 COMPANY VALUATION & FINANCIAL METRICS
  • 13.7.1 FINANCIAL METRICS
  • 13.7.2 COMPANY VALUATION
• 13.8 BRAND/PRODUCT COMPARISON
• 13.9 COMPETITIVE SCENARIO
  • 13.9.1 PRODUCT LAUNCHES & APPROVALS
  • 13.9.2 DEALS

14 COMPANY PROFILES

• 14.1 KEY PLAYERS
  • 14.1.1 GE HEALTHCARE
    • 14.1.1.1 Business overview
    • 14.1.1.2 Products offered
    • 14.1.1.3 Recent developments
      • 14.1.1.3.1 Product launches, approvals, and upgrades
      • 14.1.1.3.2 Deals
      • 14.1.1.3.3 Other developments
    • 14.1.1.4 MnM view
      • 14.1.1.4.1 Right to win
      • 14.1.1.4.2 Strategic choices
      • 14.1.1.4.3 Weaknesses & competitive threats
  • 14.1.2 PHILIPS HEALTHCARE
    • 14.1.2.1 Business overview
    • 14.1.2.2 Products offered
    • 14.1.2.3 Recent developments
      • 14.1.2.3.1 Product launches & approvals
      • 14.1.2.3.2 Deals
    • 14.1.2.4 MnM view
      • 14.1.2.4.1 Right to win
      • 14.1.2.4.2 Strategic choices
      • 14.1.2.4.3 Weaknesses & competitive threats
  • 14.1.3 CANON MEDICAL SYSTEMS CORPORATION
    • 14.1.3.1 Business overview
    • 14.1.3.2 Products offered
    • 14.1.3.3 Recent developments
      • 14.1.3.3.1 Product launches
      • 14.1.3.3.2 Deals
      • 14.1.3.3.3 Expansions
    • 14.1.3.4 MnM view
      • 14.1.3.4.1 Right to win
      • 14.1.3.4.2 Strategic choices
      • 14.1.3.4.3 Weaknesses & competitive threats
  • 14.1.4 SIEMENS HEALTHINEERS AG
    • 14.1.4.1 Business overview
    • 14.1.4.2 Products offered
    • 14.1.4.3 Recent developments
      • 14.1.4.3.1 Product launches
      • 14.1.4.3.2 Deals
      • 14.1.4.3.3 Expansions
    • 14.1.4.4 MnM view
      • 14.1.4.4.1 Right to win
      • 14.1.4.4.2 Strategic choices
      • 14.1.4.4.3 Weaknesses & competitive threats
  • 14.1.5 FUJIFILM CORPORATION
    • 14.1.5.1 Business overview
    • 14.1.5.2 Products offered
    • 14.1.5.3 Recent developments
      • 14.1.5.3.1 Product launches
      • 14.1.5.3.2 Deals
      • 14.1.5.3.3 Expansions
    • 14.1.5.4 MnM view
      • 14.1.5.4.1 Right to win
      • 14.1.5.4.2 Strategic choices
      • 14.1.5.4.3 Weaknesses & competitive threats
  • 14.1.6 HOLOGIC, INC.
    • 14.1.6.1 Business overview
    • 14.1.6.2 Products offered
    • 14.1.6.3 Recent developments
      • 14.1.6.3.1 Product launches
      • 14.1.6.3.2 Deals
      • 14.1.6.3.3 Expansions
  • 14.1.7 SAMSUNG ELECTRONICS CO., LTD.
    • 14.1.7.1 Business overview
    • 14.1.7.2 Products offered
    • 14.1.7.3 Recent developments
      • 14.1.7.3.1 Product launches
      • 14.1.7.3.2 Deals
      • 14.1.7.3.3 Other developments
  • 14.1.8 MINDRAY MEDICAL INTERNATIONAL LIMITED
    • 14.1.8.1 Business overview
    • 14.1.8.2 Products offered
    • 14.1.8.3 Recent developments
      • 14.1.8.3.1 Product launches
      • 14.1.8.3.2 Deals
  • 14.1.9 ESAOTE SPA
    • 14.1.9.1 Business overview
    • 14.1.9.2 Products offered
    • 14.1.9.3 Recent developments
      • 14.1.9.3.1 Product launches
      • 14.1.9.3.2 Deals
  • 14.1.10 CHISON MEDICAL TECHNOLOGIES CO., LTD.
    • 14.1.10.1 Business overview
    • 14.1.10.2 Products offered
    • 14.1.10.3 Recent developments
      • 14.1.10.3.1 Product launches
      • 14.1.10.3.2 Deals
  • 14.1.11 NEUSOFT MEDICAL SYSTEMS CO., LTD.
    • 14.1.11.1 Business overview
    • 14.1.11.2 Products offered
    • 14.1.11.3 Recent developments
      • 14.1.11.3.1 Product launches
  • 14.1.12 KONICA MINOLTA, INC
    • 14.1.12.1 Business overview
    • 14.1.12.2 Products offered
  • 14.1.13 CLARIUS
    • 14.1.13.1 Business overview
    • 14.1.13.2 Products offered
    • 14.1.13.3 Recent developments
      • 14.1.13.3.1 Product launches
      • 14.1.13.3.2 Deals
  • 14.1.14 MEDGYN PRODUCTS, INC.
    • 14.1.14.1 Business overview
    • 14.1.14.2 Products offered
  • 14.1.15 PROMED TECHNOLOGY CO., LTD.
    • 14.1.15.1 Business overview
    • 14.1.15.2 Products offered
• 14.2 OTHER COMPANIES
  • 14.2.1 WHITE EAGLE SONIC TECHNOLOGIES, INC.
  • 14.2.2 SHENZHEN RICSO TECHNOLOGY CO., LTD.
  • 14.2.3 YOUKEY MEDICAL
  • 14.2.4 SIUI
  • 14.2.5 TELEMED, MEDICAL IMAGING EQUIPMENT DESIGN & MANUFACTURING
  • 14.2.6 BUTTERFLY NETWORK, INC.
  • 14.2.7 ALPINION MEDICAL SYSTEMS
  • 14.2.8 EDAN INSTRUMENTS, INC.
  • 14.2.9 SHENZHEN LANDWIND INDUSTRY CO., LTD.
  • 14.2.10 ECHONOUS INC.
  • 14.2.11 MOBISANTE, INC.
  • 14.2.12 SHENZHEN WISONIC MEDICAL TECHNOLOGY CO., LTD.
  • 14.2.13 SHENZHEN BIOCARE BIO-MEDICAL EQUIPMENT CO., LTD.
  • 14.2.14 SONOSCAPE MEDICAL CORP.
  • 14.2.15 CURA HEALTHCARE

15 APPENDIX

• 15.1 DISCUSSION GUIDE
• 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 15.3 CUSTOMIZATION OPTIONS
• 15.4 RELATED REPORTS
• 15.5 AUTHOR DETAILS